Common Cholesterol Drug Linked to Lower Dementia Risk When Started Early
Starting statin therapy shortly after a type 2 diabetes diagnosis may not only protect the heart but also be linked to a lower dementia risk. This is according to a large study presented at the European Society of Cardiology Congress in Munich on August 30.
Key Findings:
- Adults who began taking a statin within one year of their type 2 diabetes diagnosis had a 15% lower relative risk of developing dementia over 10 years compared to those who did not start within five years.
- Even for those who delayed starting a statin for one to five years, there was still a 10% lower relative risk.
Study Details:
Researchers conducted the study using health data from 132,585 patients in Denmark diagnosed with type 2 diabetes between 2006 and 2019. These patients had no prior history of statin use or dementia.
During a median follow-up of 7.1 years, the team analyzed the timing of statin initiation and its association with dementia risk.
Statins and Dementia Prevention:
A statin is a prescription medication that lowers "bad" LDL cholesterol, helping to reduce the risk of heart attack and stroke. The study's findings suggest that early statin use may have additional benefits for cognitive health.
Remember that while these findings are promising, further research is needed to confirm these results and understand the underlying mechanisms.